nubimax 250mg injection - Bivalirudin (250mg) medicine

Bivasave 250mg Injection (bivalirudin): Comprehensive Medicine Guide

No reviews yet
🏭 Emcure Pharmaceuticals Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 28, 2026
📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: High for approved indications.
Reviewed by
SaathiMed Expert Panel | Oct 28, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Severe or uncontrolled bleeding from any site
  • Black, tarry stools or vomiting blood
  • Sudden severe headache, confusion, or weakness
  • Difficulty breathing or swelling of face, lips, or throat
  • Chest pain or palpitations
  • Decreased urine output or swelling in legs
  • Unusual bruising or petechiae

If experiencing severe symptoms, call emergency services immediately.

What is nubimax 250mg injection used for?

This medicine is a direct thrombin inhibitor given intravenously during certain heart procedures to prevent blood clots. It is used in hospital settings and requires close monitoring for bleeding.

  • Generic Name: Bivalirudin (250mg)
  • Manufacturer: Emcure Pharmaceuticals Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 nubimax 250mg injection के बारे में (Hindi Summary)

उपयोग: यह दवा बाइवलिरुडिन 250 मिलीग्राम इंजेक्शन के रूप में अस्पताल में विशेष हृदय प्रक्रियाओं के दौरान खून के थक्के बनने से रोकने के लिए दी जाती है। यह सीधे थ्रोम्बिन को रोककर काम करती है और हेपरिन से एलर्जी या हेपरिन-प्रेरित थ्रोम्बोसाइटोपेनिया वाले रोगियों में उपयोगी होती है। इसे केवल प्रशिक्षित डॉक्टर या नर्स द्वारा ही नस में दिया जाता है।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में इंजेक्शन स्थल पर हल्का रक्तस्राव, पीठ दर्द, मतली, सिरदर्द और निम्न रक्तचाप शामिल हैं। गंभीर दुष्प्रभावों में अत्यधिक रक्तस्राव, एलर्जी प्रतिक्रिया और थ्रोम्बोसाइटोपेनिया हो सकते हैं। कोई भी असामान्य रक्तस्राव या लक्षण दिखने पर तुरंत डॉक्टर को बताएं।

सुरक्षा सलाह: यह दवा केवल अस्पताल में डॉक्टर की देखरेख में ही दी जानी चाहिए। इसे घर पर स्वयं न लगाएं। अपने डॉक्टर को सभी दवाओं के बारे में बताएं, खासकर खून पतला करने वाली दवाएं। गर्भावस्था या स्तनपान के दौरान डॉक्टर से सलाह लें। उपचार के दौरान चोट लगने वाली गतिविधियों से बचें और रक्तस्राव के किसी भी संकेत को तुरंत बताएं।

💡 Did You Know? India is the largest provider of generic medicines globally, supplying over 50% of global vaccine demand.

💊 nubimax 250mg injection Uses & Benefits

[{"condition":"Percutaneous coronary intervention (PCI)","description":"Used as an anticoagulant during angioplasty and stent placement to prevent clot formation in the coronary arteries.","evidence":"Well-established"},{"condition":"Heparin-induced thrombocytopenia (HIT)","description":"Provides anticoagulation in patients who cannot receive heparin due to immune-mediated platelet destruction.","evidence":"Well-established"},{"condition":"Acute coronary syndrome undergoing invasive management","description":"Used in selected patients during catheterization procedures to reduce thrombotic complications.","evidence":"Established"}]

Off-label uses: [{"condition":"Anticoagulation in extracorporeal circuits","description":"Occasionally used in specialized settings such as cardiopulmonary bypass or dialysis circuits when heparin is contraindicated.","evidence":"Limited"}]

Primary treatment for: Percutaneous coronary intervention (PCI)

Also treats: Heparin-induced thrombocytopenia, Acute coronary syndrome

📋 Drug Information

Generic Name(s)Bivalirudin (250mg)
Brand Namenubimax 250mg injection
ManufacturerEmcure Pharmaceuticals Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassCARDIAC
Action ClassDirect thrombin inhibitor- parenteral
Route of AdministrationParenteral (intravenous bolus and/or continuous intravenous infusion)
StorageStore unopened vials at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. Once reconstituted or diluted, the solution should be used immediately or stored as per institutional guidelines, typically at room temperature and used within a specified time.
Shelf LifeRefer to the manufacturer's packaging for the exact shelf life. Typically, unopened vials have a shelf life of 24 to 36 months when stored properly.
WHO GuidelineNot established from the available information. Guidelines from professional cardiology societies may include recommendations for bivalirudin in specific settings; consult current guidelines.
ICMR GuidelineNot established from the available information. Refer to Indian Council of Medical Research guidelines for anticoagulation in cardiac procedures.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Administer this medicine only in a setting equipped to monitor and manage bleeding complications.
2
Calculate the dose based on the patient's weight and renal function before administration.
3
Monitor activated clotting time (ACT) during PCI to ensure adequate anticoagulation.
4
Be prepared to manage anaphylaxis; keep emergency drugs and equipment ready.
5
Avoid concomitant use with other anticoagulants unless clearly indicated and closely monitored.
6
In patients with renal impairment, reduce the infusion rate and monitor closely for bleeding.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Chest pain during cardiac procedure
This medicine is used to prevent clots during procedures.
Likely Use
✅
History of heparin-induced thrombocytopenia
This medicine is an alternative anticoagulant for HIT.
Likely Use
❌
Fever
This medicine is not used to treat fever.
Not Primary
❌
High blood pressure
This medicine is not used for blood pressure control.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is administered intravenously, so absorption from the gastrointestinal tract is not applicable. It is directly delivered into the bloodstream, producing immediate systemic availability.
DistributionThis medicine distributes primarily within the intravascular space and extracellular fluid. It does not extensively bind to tissues, and its volume of distribution is relatively small, consistent with a hydrophilic peptide.
Protein BindingThis medicine does not bind significantly to plasma proteins, which contributes to its predictable anticoagulant effect.
MetabolismThis medicine is metabolized mainly by proteolytic cleavage, including by thrombin itself, and to a lesser extent by other plasma proteases. Renal excretion also contributes to its elimination.
Half-LifeThe elimination half-life of this medicine is approximately 25 minutes in patients with normal renal function, but it is prolonged in patients with renal impairment.
ExcretionThis medicine is excreted primarily through the kidneys, with about 20% of the dose recovered unchanged in urine. Renal impairment significantly reduces its clearance.
BioavailabilityBioavailability is 100% when administered intravenously, as this medicine is given directly into the bloodstream.
Onset of ActionAnticoagulant effect begins immediately after intravenous administration, within minutes.
Peak Plasma TimePeak plasma concentration occurs immediately at the end of intravenous bolus or during steady-state infusion.
Duration of ActionThe anticoagulant effect persists for approximately 1 to 2 hours after stopping the infusion in patients with normal renal function, but may be longer in renal impairment.

How It Works

This medicine directly and reversibly inhibits thrombin by binding to both its catalytic site and its anion-binding exosite. By blocking thrombin, it prevents the conversion of fibrinogen to fibrin, inhibits thrombin-mediated platelet activation, and reduces clot formation. Unlike heparin, its action does not depend on antithrombin III, which makes it effective even in patients with heparin-induced thrombocytopenia.

Mechanism Steps

1
Direct binding to thrombin: This medicine binds directly to the catalytic site and exosite 1 of thrombin without requiring antithrombin III.
2
Inhibition of fibrin formation: By blocking thrombin, this medicine prevents the conversion of fibrinogen to fibrin, which is essential for clot formation.
3
Reduction of platelet activation: Thrombin is a potent platelet activator; its inhibition reduces platelet aggregation and further clot propagation.
4
Reversible anticoagulation: The inhibition is reversible, and anticoagulant effect declines rapidly after stopping the infusion, allowing for quick restoration of clotting ability.

💡 How to Take nubimax 250mg injection

Strength: 250 mg lyophilized powder for injection (reconstituted for intravenous use)

1This medicine is given by a healthcare professional in a hospital or clinic setting.
2It is administered as an intravenous bolus followed by a continuous infusion.
3The dose and rate are determined by your doctor based on your weight, kidney function, and the procedure.
4You will be monitored closely for bleeding and other side effects during and after administration.
5Do not attempt to self-administer this medicine at home.

Dosage Information

Adult DosageThe dose of this medicine is individualized by a qualified clinician based on the indication, patient weight, renal function, and whether it is used as a bolus or continuous infusion. For percutaneous coronary intervention, a common regimen is an intravenous bolus of 0.75 mg/kg followed by an infusion of 1.75 mg/kg/hour for the duration of the procedure. For patients with heparin-induced thrombocytopenia, dosing may differ. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician.
Elderly DosageElderly patients may have reduced renal function and are at higher risk of bleeding. Dose should be individualized by a qualified clinician, and renal function should be monitored closely.
Renal ImpairmentIn patients with renal impairment, the dose of this medicine must be reduced. For moderate renal impairment (CrCl 30-59 mL/min), a dose reduction is recommended. For severe renal impairment (CrCl <30 mL/min), the infusion rate should be reduced further, and in dialysis-dependent patients, the dose should be adjusted according to institutional protocols. Dose must be individualized by a qualified clinician based on renal function.
Hepatic ImpairmentNo specific dose adjustment is established for hepatic impairment. Use with caution and monitor for bleeding, as liver dysfunction may affect coagulation. Dose must be individualized by a qualified clinician.
Maximum Daily DoseNot established from the available information. The maximum dose is determined by the clinical scenario and should not exceed the recommended regimen for the specific indication.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

No specific food interactions
Not applicable
This medicine is given intravenously in a hospital setting; food does not affect its action.

⏰ What to Do If You Miss a Dose

📌 Missed dose during continuous infusion in hospital
→ Inform the nursing staff immediately.
💡 The infusion will be adjusted according to protocol; do not attempt to self-administer.
📌 Missed follow-up appointment after discharge
→ Contact your doctor to reschedule as soon as possible.
💡 Do not change any medication without medical advice.

⚠️ Side Effects of nubimax 250mg injection

✅ Common Side Effects

Minor bleeding at puncture site (Common (up to 10%))
Apply pressure to the site and inform nursing staff. Usually resolves without intervention.
Back pain (Common (5-10%))
Report to your doctor; it may be managed with simple analgesics if appropriate.
Nausea (Common (5-10%))
Inform the medical team; antiemetics may be given if needed.
Headache (Common (5-10%))
Report persistent or severe headache to rule out bleeding.
Hypotension (Common (5-10%))
Medical staff will monitor blood pressure and manage with fluids or vasopressors if necessary.

🚨 Serious Side Effects

Major bleeding (gastrointestinal, intracranial, retroperitoneal) (Uncommon (1-5%))
Seek immediate medical attention if you notice black stools, vomiting blood, severe abdominal pain, sudden severe headache, confusion, or weakness.
Anaphylaxis (Rare (<0.1%))
Emergency treatment with epinephrine and supportive care is required. Inform staff of any allergies before administration.
Thrombocytopenia (Rare (<0.1%))
Monitor platelet counts; report unusual bruising or bleeding.
Coronary artery thrombosis (Rare (<0.1%))
Report chest pain immediately; may require urgent intervention.

⚠️ Rare Side Effects

Pulmonary hemorrhage
Seek emergency care for coughing up blood or difficulty breathing.
Intracranial hemorrhage
Immediate medical attention for sudden severe headache, vomiting, or neurological deficits.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Warfarin Major
Dabigatran Major
Alteplase Major
Eptifibatide Major
Aspirin Moderate
Clopidogrel Moderate
Ibuprofen Moderate
Naproxen Moderate
Heparin Moderate
Cefoperazone Minor

🚨 Major Interactions

  • Warfarin
  • Direct oral anticoagulants (e.g., dabigatran, rivaroxaban)
  • Thrombolytic agents (e.g., alteplase)
  • Glycoprotein IIb/IIIa inhibitors (e.g., eptifibatide, tirofiban)

⚡ Moderate Interactions

  • NSAIDs (e.g., ibuprofen, naproxen)
  • Antiplatelet agents (e.g., aspirin, clopidogrel)
  • Heparin

🍷 Alcohol Interaction

Alcohol may increase the risk of gastrointestinal bleeding and should be avoided while receiving this medicine. Patients should not consume alcohol during treatment and for at least 24 hours after discontinuation unless otherwise advised by their doctor.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Active major bleeding","Severe uncontrolled hypertension","Known hypersensitivity to bivalirudin or any component of the formulation","Recent intracranial hemorrhage or surgery","Severe renal impairment without dose adjustment (relative contraindication)"]

⚠️ Warnings & Precautions

["This medicine must be administered only by healthcare professionals in a setting equipped to monitor and manage bleeding complications.","Bleeding risk is increased in patients with renal impairment, elderly patients, and those on concomitant anticoagulants or antiplatelet agents.","Dose adjustment is required in patients with moderate to severe renal impairment.","Monitor for signs of anaphylaxis; have emergency treatment readily available.","Avoid intramuscular injections and unnecessary invasive procedures during treatment.","Use with caution in patients with recent stroke, bleeding disorders, or severe liver disease."]

🤱 Lactation Safety

Not established from the available information. It is not known whether this medicine is excreted in human breast milk. Breastfeeding should be avoided during treatment and for at least 24 hours after the last dose unless advised otherwise by a doctor.

💊 Overdose Management

Overdose of this medicine can cause severe bleeding. There is no specific antidote. Management includes immediate discontinuation of the infusion, supportive care, and control of bleeding. In cases of life-threatening hemorrhage, consider administration of fresh frozen plasma, packed red blood cells, or recombinant factor VIIa as clinically indicated. Renal function should be assessed, and dialysis may be considered in patients with renal failure.

⏰ Missed Dose

This medicine is given by healthcare professionals in a controlled setting, so missed doses are unlikely to occur outside the hospital. If a dose is missed during a continuous infusion, the medical team will adjust the infusion rate according to protocol. Do not attempt to self-administer or adjust the dose.

Additional Safety Advice

General Safety

This medicine must only be given by a qualified healthcare professional in a monitored setting. Do not attempt to self-administer this injection. Inform your doctor about all medicines you take, especially blood thinners, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs, because the risk of bleeding increases. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. Avoid activities that can cause injury or bleeding until your doctor confirms it is safe. Report any signs of bleeding, allergic reaction, or unusual symptoms immediately. Do not stop or change the dose without medical advice.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients are at higher risk of bleeding and may have reduced renal function. Dose adjustment and close monitoring are required. Falls and injuries should be avoided.

🤰 Pregnancy Planning (TTC)

Not established from the available information. If you are planning pregnancy, discuss with your doctor. This medicine is used only in acute hospital settings, and its use during pregnancy should be based on a risk-benefit assessment.

🏥 Post-Surgery Considerations

This medicine is often used during surgery or procedures. After surgery, monitor for bleeding and follow your surgeon's instructions. Avoid strenuous activity and follow wound care advice.

🦷 Dental Procedures

Inform your dentist if you have recently received this medicine. Dental procedures may need to be postponed until your bleeding risk is normalized. Your doctor will advise on the timing.

💚 Lifestyle Tips for Better Results

🏃
Follow a heart-healthy diet low in saturated fats and salt.
🥗
Engage in regular physical activity as advised by your doctor.
😴
Avoid smoking and limit alcohol consumption.
💧
Take all prescribed medications exactly as directed.
🧘
Keep all follow-up appointments for monitoring.
🌞
Maintain a healthy weight to reduce strain on your heart.

🏋️ Exercise Considerations

Avoid strenuous exercise or activities that may cause injury or bleeding until your doctor confirms it is safe. Light walking is generally encouraged after discharge, but follow your doctor's specific advice.

🥗 Diet Recommendations

Eat a balanced diet rich in fruits, vegetables, and whole grains.
Limit foods high in saturated fats and trans fats.
Reduce salt intake to manage blood pressure.
Stay well hydrated unless fluid restriction is advised.
Avoid excessive alcohol consumption.

💼 Impact on Daily Work & Life

After receiving this medicine, you may feel tired or dizzy. Do not drive or operate heavy machinery until you feel fully alert and your doctor approves. Most patients can resume normal activities within a few days, depending on the procedure and their overall health.

🛑 When to Stop This Medicine

This medicine is stopped by your healthcare provider when it is no longer needed, typically after the procedure or when anticoagulation is no longer required. Do not stop any medication on your own. If you experience severe bleeding or an allergic reaction, the infusion will be stopped immediately by medical staff.

📅 Long-Term Use Effects

This medicine is typically used for short durations during hospital procedures. Long-term effects are not well established because it is not intended for chronic use. Prolonged use may increase the risk of bleeding. Monitoring of renal function and bleeding parameters is required if used for extended periods.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Argatroban

Another direct thrombin inhibitor used as an alternative in HIT.

Evidence: Well-established
Fondaparinux

A factor Xa inhibitor that can be used in HIT.

Evidence: Established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Not established from the available information. There are no known interactions between this medicine and vaccines. However, avoid intramuscular injections (including some vaccines) while on this medicine due to bleeding risk. Consult your doctor for timing.

📦 Storage Guide

✅ DO

Store unopened vials in the refrigerator (2°C to 8°C).

❌ DON'T

Do not freeze the vials.

✅ DO

Protect from light by keeping in the original carton.

❌ DON'T

Do not use if the solution is discolored or contains particles.

✅ DO

Follow institutional guidelines for storage after reconstitution.

❌ DON'T

Do not store reconstituted solution for extended periods unless specified.

✈️ Traveling with This Medicine

This medicine is administered only in a hospital setting, so travel advice is not applicable for self-administration. If you are discharged on other medications, carry a copy of your prescription and discharge summary. For air travel, keep medicines in original packaging with a prescription. If you have recently received this medicine, avoid prolonged sitting during travel to reduce clot risk, and stay hydrated. Inform your doctor before any travel.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 62-year-old man with heparin-induced thrombocytopenia undergoing cardiac catheterization.
He was started on this medicine as an alternative anticoagulant during the procedure. His platelet count was monitored closely, and no bleeding complications occurred. He was transitioned to an oral anticoagulant after the procedure.
💡 Lesson: This medicine is an effective alternative for patients who cannot receive heparin, but close monitoring is essential.
👤 A 55-year-old woman with chronic kidney disease undergoing percutaneous coronary intervention.
Her dose was adjusted based on her renal function. She experienced minor oozing from the catheter site, which was managed with pressure. No major bleeding occurred.
💡 Lesson: Renal dose adjustment is critical to prevent excessive anticoagulation and bleeding.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts working immediately after intravenous administration, within minutes.

Q: How is this medicine given?

A: It is given as an intravenous bolus followed by a continuous infusion by a healthcare professional.

Q: What are the common side effects?

A: Common side effects include minor bleeding, back pain, nausea, headache, and low blood pressure.

Q: Is this medicine safe in kidney disease?

A: Dose adjustment is required in kidney disease. Your doctor will adjust the dose based on your renal function.

Q: Can I drive after receiving this medicine?

A: No, you should not drive or operate machinery immediately after receiving this medicine. Follow your doctor's advice.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine at home?
  • How long will I need this medicine?
  • Will it affect my kidney function?
  • Can I take other blood thinners with this?
  • What if I miss a dose?
  • Can I breastfeed while on this medicine?

🔄 Substitutes for nubimax 250mg injection

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: Bivalirudin is a general blood thinner that can be taken at home.
    Fact: This medicine is given only by healthcare professionals in a hospital setting for specific procedures.
  • Myth: Bivalirudin is the same as heparin.
    Fact: Bivalirudin is a direct thrombin inhibitor and works differently from heparin; it does not require antithrombin III.
  • Myth: You can stop bivalirudin on your own if you feel better.
    Fact: Only your doctor can decide when to stop this medicine; stopping prematurely can increase the risk of clots.

🔄 Alternative Options

Generic Alternatives

  • Bivalirudin

Brand Alternatives

  • Bivasave 250mg injection

📊 Comparison with Similar Medicines

[{"medicine":"Bivalirudin","class":"Direct thrombin inhibitor","route":"Intravenous","half_life":"~25 minutes","renal_adjustment":"Yes"},{"medicine":"Argatroban","class":"Direct thrombin inhibitor","route":"Intravenous","half_life":"~45 minutes","renal_adjustment":"No (hepatic adjustment)"},{"medicine":"Lepirudin","class":"Direct thrombin inhibitor","route":"Intravenous","half_life":"~1.3 hours","renal_adjustment":"Yes"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory